Colleen M. Novak
Mayo Clinic
Endocrine Research Unit
200 1st Street Southwest
Saint Marys Hospital
USA
Name/email consistency: high
- Neuromedin S and U. Novak, C.M. Endocrinology (2009)
- Endurance capacity, not body size, determines physical activity levels: role of skeletal muscle PEPCK. Novak, C.M., Escande, C., Gerber, S.M., Chini, E.N., Zhang, M., Britton, S.L., Koch, L.G., Levine, J.A. PLoS. ONE (2009)
- Daily intraparaventricular orexin-A treatment induces weight loss in rats. Novak, C.M., Levine, J.A. Obesity. (Silver. Spring) (2009)
- Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Novak, C.M., Zhang, M., Levine, J.A. Brain Res. (2007)
- Associations between behavior, hormones, and Fos responses to novelty differ in pre- and post-pubertal grass rats. Novak, C.M., Parfitt, D.B., Sisk, C.L., Smale, L. Physiol. Behav. (2007)
- Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity. Novak, C.M., Levine, J.A. J. Neuroendocrinol. (2007)
- Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. Novak, C.M., Zhang, M., Levine, J.A. J. Neuroendocrinol. (2006)
- Light and GABA)(A) receptor activation alter period mRNA levels in the SCN of diurnal Nile grass rats. Novak, C.M., Ehlen, J.C., Paul, K.N., Fukuhara, C., Albers, H.E. Eur. J. Neurosci. (2006)
